ArticleFrontiers in medicine2026
Case Report: Adult-onset diffuse hepatic hemangiomatosis with rapid progression: an autopsy case with diagnostic difficulty.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse hepatic hemangiomatosis (DHH) in adults is a rare benign vascular tumor of the liver that histologically resembles a hepatic hemangioma but is characterized by an infiltrative growth pattern despite the absence of cytologic atypia typical of hepatic angiosarcoma. Although generally indolent, its clinical course is variable, and rapidly progressive or fatal cases have been reported. Due to its rarity and overlapping radiological and histopathological features with those of other vascular lesions, its diagnosis can be challenging. We present the case of a 51-year-old female with multiple hepatic lesions, initially suspected to be hepatic hemangiomas. Six months later, the lesions had progressed rapidly. A percutaneous liver biopsy revealed dilated sinusoids lined with endothelial cells without marked atypia, thus suggesting a benign vascular lesion. However, the rapid clinical course raised concerns regarding hepatic angiosarcoma, and the patient received weekly paclitaxel followed by durvalumab. No therapeutic response was observed, and the patient died of tumor rupture. Autopsy revealed diffuse replacement of the hepatic parenchyma with multiloculated cystic vascular spaces lined with pleomorphic endothelial cells. No histological heterogeneity or extrahepatic lesions are observed. These findings supported the diagnosis of DHH. This case report contributes to the current knowledge of the clinical and pathological features of this rare entity. In addition, pleomorphic endothelial cells observed during autopsy may be attributable to treatment-related artifacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.